adminの記事一覧

Effect of red wine on urinary protein, 8-hydroxydeoxyguanosine, and liver-type fatty acid-binding protein excretion in patients with diabetic nephropathy.

Metabolism. 58(8): 1185-1190, 2009.PubMed

Amelioration of diabetic tubulointerstitial damage in liver-type fatty acid-binding protein transgenic mice.

Nephrol Dial Transplant. 24(3): 788-800, 2009.PubMed

Urinary human L-FABP is a potential biomarker to predict COX-inhibitor-induced renal injury.

Nephron Exp Nephrol. 108(1): e19-26, 2008.PubMed

Liver fatty acid-binding protein as a biomarker of acute kidney injury after cardiac surgery.

Kidney Int. 73(4): 465-472, 2008.PubMed

Renal L-type fatty acid-binding protein mediates the bezafibrate reduction of cisplatin-induced acute kidney injury.

Kidney Int. 73(12): 1374-1384, 2008.PubMed

Renoprotective effect of telmisartan in patients with chronic kidney disease.

Clin Exp Hypertens. 30(7): 662-672, 2008.PubMed

Additional renoprotective effects of azelnidipine combined with angiotensin receptor blockers in patients with diabetic nephropathy.

Clin Nephrol. 70(5): 385-392, 2008.PubMed

L-Type Fatty Acid Binding Protein Transgenic Mouse as a Novel Tool to Explore Cytotoxicity to Renal Proximal Tubules.

Drug Metab. Pharmacokinet. 23(4): 271-278, 2008.PubMed

Renal L-type fatty acid-binding protein in acute ischemic injury.

J Am Soc Nephrol. 18(11): 2894-2902, 2007.PubMed

Angiotensin II receptor antagonist reduces urinary liver-type fatty acid-binding protein levels in patients with diabetic nephropathy and chronic renal failure.

Diabetologia. 50(2): 490-492, 2007.PubMed